SCHEMBL16203403

SCHEMBL16203403

CC(C)c1cc(Br)cc(-c2ccccc2)c1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.41
GABRB1 P18505 1/20 0.41
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
AKR1C1 Q04828 1/20 0.39
ALDH1A1 P00352 5/20 0.35
HSD17B10 Q99714 3/20 0.35
MAPK1 P28482 3/20 0.35
P2RX3 P56373 1/20 0.35
P2RX2 Q9UBL9 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
HSP90AA1 P07900 1/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
ESR1 P03372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16203407 0.82 IKBKB (0.42) ALDH1A1HSD17B10P2RX3P2RX2CA12
SCHEMBL31243809 0.81 AKR1C3 (0.48) AKR1C3AKR1C2AKR1C1ALDH1A1HSD17B10
SCHEMBL24061499 0.81 NUDT1 (0.43) ALDH1A1HSD17B10MAPK1P2RX3P2RX2
SCHEMBL20754892 0.79 METAP2 (0.37) AKR1C3AKR1C2AKR1C1ALDH1A1HSD17B10
SCHEMBL30597431 0.77 ALDH1A1 (0.52) AKR1C3AKR1C2AKR1C1ALDH1A1HSD17B10
SCHEMBL27333267 0.77 ALDH1A1 (0.38) ALDH1A1HSD17B10MAPK1P2RX3P2RX2
SCHEMBL636376 0.77 GABRA1 (0.58) GABRA1GABRB1CA1CA2POLB
SCHEMBL15975997 0.77 ESR2 (0.44) AKR1C3AKR1C2AKR1C1ALDH1A1HSD17B10
Bromide SCHEMBL9491638 0.75 GABRA1 (0.56) GABRA1GABRB1CA1CA2POLB
SCHEMBL16203402 0.74 CA1 (0.46) GABRA1GABRB1ALDH1A1HSD17B10CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160079547-A1 BLUE LUMINESCENT COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY 2016-03-17 US disclosed
WO-2014176159-A9 BLUE LUMINESCENT COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2015-02-19 WO disclosed
WO-2014176159-A1 BLUE LUMINESCENT COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2014-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160079547-A1 BLUE LUMINESCENT COMPOUNDS HBS1L, IK, LAS1L GABRA1 4208/4885GABRB1 4218/4885AKR1C3 1830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.